• Profile
Close

Clinical efficacy of submucosal injection of triamcinolone acetonide in the treatment of type II/III interstitial cystitis/bladder pain syndrome

BMC Urology Apr 02, 2020

Jiang T, Zhou X, Chen Z, et al. - The effectiveness of submucosal injection of triamcinolone acetonide for the treatment of type II/III interstitial cystitis/bladder pain syndrome was evaluated. Researchers performed a retrospective analysis of the clinical data of type II/III interstitial cystitis/bladder pain syndrome patients treated in our department from April 2016 to August 2018, and changes in International Prostate Symptom Scores and the Pelvic Pain and Urgency/Frequency symptom scale after surgery were examined to investigate factors that may affect patient outcomes. This study included a sum of 27 female individuals and 8 male patients, with type II patients accounting for 62.9% of the sample, and the median follow-up duration was 31 months (range: 12–40 months). In both men and women with type II/III interstitial cystitis/bladder pain syndrome, study reveals that submucosal injection of triamcinolone acetonide can enhance the clinical symptoms and quality of life. The study found that triamcinolone acetonide injection can be useful in patients with an advanced age and more severe interstitial cystitis/bladder pain syndrome related symptoms.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free.
  • 55 lakhs+ doctors trust M3 globally

  • Nonloggedininfinity icon
    Unlimited access to original articles by experts
  • Nonloggedinlock icon
    Secure: we never sell your data
  • Signing up takes less than 2 mins
Try M3 India / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay